FDA 510(k) · Microlife Intellectual Property
K120430: MICROLIFE WRIST WATCH BLOOD PREEURE MONITOR, BP3MO1-3P (Microlife Intellectual Property GmbH)
Microlife Intellectual Property GmbH received FDA 510(k) K120430 for MICROLIFE WRIST WATCH BLOOD PREEURE MONITOR, BP3MO1-3P, with a decision date of Aug 2, 2012 (substantially equivalent).
Prescription or OTC: Unknown (no FDA document we parsed states it).
FDA facts
| FDA number | K120430 |
|---|---|
| Pathway | 510(k) |
| Applicant | Microlife Intellectual Property GmbH |
| Device name | MICROLIFE WRIST WATCH BLOOD PREEURE MONITOR, BP3MO1-3P |
| Product code | DXN: System, Measurement, Blood-Pressure, Non-Invasive |
| Regulation (21 CFR) | 870.1130 |
| Device class | Class 2 |
| Date received | Feb 13, 2012 |
| Decision date | Aug 2, 2012 |
| Decision | Substantially Equivalent (SESE) |
| 510(k) type | Special |
Source: openFDA device 510(k) data, data through Oct 26, 2026.
Indications for use parsed from FDA documents
51 0(k) Number (if known): 2 {L 30 Device Name: Microlife Wrist Watch Blood Pressure Monitor, Model BP3MOI1-3P Indications For Use: The Microlife Wrist Watch Blood Pressure Monitor, Model BP3MO1-3P is a device* initended to measure the systolic and diastolic blood pressure and pulse rate of an adult individual by using a non-invasive oscillometric technique in which an inflatable cuff is wrapped around the wrist for a circumference range from 13.5 to 21.5cm. The device detects the appearance of irregular heartbeat during measurement and gives a warning signal with the reading once the irregular heartbeat is detected. Prescription Use _____ ANDIOR Over-The-Counter Use -X (Part 21 CFR 801 Subpart 0) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Page 1 Of I Division of Cardiovascular Devices 510(k) Number~YlL2&2~-
Extracted automatically from FDA's 510(k) summary. It can contain extraction errors and is not a verified quote. Read the wording in the FDA PDF before relying on it.
Predicates parsed from FDA documents
FDA numbers found next to the word "predicate" in the summary. The list can include reference devices; check the PDF for which device is the primary predicate.
Later records that cite K120430
ChatPPG interpretation
A 510(k) decision of "substantially equivalent" means FDA found the device as safe and effective as a legally marketed predicate. FDA's word for this is cleared, not approved. The clearance covers the device and indications in this submission; it does not extend to other features or versions of the same product that were not part of it. See FDA cleared vs approved.
Product code DXN is "System, Measurement, Blood-Pressure, Non-Invasive", class 2, 21 CFR 870.1130.
Our labels for filtering: claim Blood pressure, sensor Cuff. These are heuristics, not FDA fields.